Prospective evaluation of early treatment outcome in patients with meningiomas treated with particle therapy based on target volume definition with MRI and 68Ga-DOTATOC-PET

Abstract Purpose. To evaluate early treatment results and toxicity in patients with meningiomas treated with particle therapy. Material and methods. Seventy patients with meningiomas were treated with protons (n = 38) or carbon ion radiotherapy (n = 26). Median age was 49 years. Median age at treatment was 55 years, 24 were male (34%), and 46 were female (66%). Histology was benign meningioma in 26 patients (37%), atypical in 23 patients (33%) and anaplastic in four patients (6%). In 17 patients (24%) with skull base meningiomas diagnosis was based on the typical appearance of a meningioma. For benign meningiomas, total doses of 52.2–57.6 GyE were applied with protons. For high-grade lesions, the boost volume was 18 GyE carbon ions, with a median dose of 50 GyE applied as highly conformal radiation therapy. Nineteen patients were treated as re-irradiation. Treatment planning with MRI and 68-Ga-DOTATOC-PET was evaluated. Results. Very low rates of side effects developed, including headaches, nausea and dizziness. No severe treatment-related toxicity was observed. Local control for benign meningiomas was 100%. Five of 27 patients (19%) developed tumor recurrence during follow-up. Of these, four patients had been treated as re-irradiation for recurrent high-risk meningiomas. Actuarial local control after re-irradiation of high-risk meningiomas was therefore 67% at six and 12 months. In patients treated with primary radiotherapy, only one of 13 patients (8%) developed tumor recurrence 17 months after radiation therapy (photon and carbon ion boost). Conclusion. Continuous prospective follow-up and development of novel study concepts are required to fully exploit the long-term clinical data after particle therapy for meningiomas. To date, it may be concluded that when proton therapy is available, meningioma patients can be offered a treatment at least comparable to high-end photon therapy.

[1]  Richard Pötter,et al.  Connection of European particle therapy centers and generation of a common particle database system within the European ULICE-framework , 2012, Radiation oncology.

[2]  Hirohiko Tsujii,et al.  Particle radiation therapy using proton and heavier ion beams. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  A. Unterberg,et al.  glioblastoma: The CLEOPATRA Trial , 2022 .

[4]  J. Debus,et al.  High efficacy of fractionated stereotactic radiotherapy of large base-of-skull meningiomas: long-term results. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  U. Isacsson,et al.  Stereotactic Irradiation of Skull Base Meningiomas with High Energy Protons , 1999, Acta Neurochirurgica.

[6]  J. Slabbert,et al.  Stereotactic proton beam therapy of skull base meningiomas. , 2001, International journal of radiation oncology, biology, physics.

[7]  E. Wenkel,et al.  Benign meningioma: partially resected, biopsied, and recurrent intracranial tumors treated with combined proton and photon radiotherapy. , 2000, International journal of radiation oncology, biology, physics.

[8]  M. Bondy,et al.  Epidemiology and etiology of intracranial meningiomas: A review , 1996, Journal of Neuro-Oncology.

[9]  A. von Deimling,et al.  Carbon ion radiation therapy for high-risk meningiomas. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[10]  L. Verhey,et al.  Fractionated Proton Radiation Therapy of Cranial and Intracranial Tumors , 1990, American journal of clinical oncology.

[11]  A. Unterberg,et al.  Treatment of patients with atypical meningiomas Simpson grade 4 and 5 with a carbon ion boost in combination with postoperative photon radiotherapy: The MARCIE Trial , 2010, BMC Cancer.

[12]  Pascal Pommier,et al.  Combined proton and photon conformal radiotherapy for intracranial atypical and malignant meningioma. , 2009, International journal of radiation oncology, biology, physics.

[13]  R. Ojemann,et al.  Management of Atypical and Malignant Meningiomas: Role of High-dose, 3D-conformal Radiation Therapy , 2000, Journal of Neuro-Oncology.

[14]  G. Goitein,et al.  Spot scanning-based proton therapy for intracranial meningioma: long-term results from the Paul Scherrer Institute. , 2012, International journal of radiation oncology, biology, physics.

[15]  K. Herfarth,et al.  Comparison of intensity modulated radiotherapy (IMRT) with intensity modulated particle therapy (IMPT) using fixed beams or an ion gantry for the treatment of patients with skull base meningiomas , 2012, Radiation Oncology.

[16]  J. Debus,et al.  Radiobiological evaluation and correlation with the local effect model (LEM) of carbon ion radiation therapy and temozolomide in glioblastoma cell lines , 2008, International journal of radiation biology.